EUVIMEDEUVIMED entdecken
Crossref

Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways

Marwa Monier Mahmoud Refaie iD, Rehab Ahmed Rifaai iD, Asmaa M A Bayoumi, Sayed Shehata

Journal of Pharmacy and Pharmacology · 2023

DOI: 10.1093/jpp/rgad049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2023. Verfasst von Marwa Monier Mahmoud Refaie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia, Egypt. Hauptthemen laut MEDLINE: Cardiotoxicity, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Drug-induced cardiac injury is a potentially preventable cause of heart failure. Cisplatin (CIS) is a widely used chemotherapeutic agent complicated with cardiotoxicity that limits its clinical application so we aimed to evaluate the suspected cardioprotective effect of sacubitril/valsartan (Sac/Val) against CIS cardiotoxic injury.

Methods

Forty male rats of Wistar albino species were divided into four groups. group I received the vehicle; group II was given the vehicle plus CIS (10 mg/kg) single i.p. on fifth day; group III was given Sac/Val (30 mg/kg/d) orally for 7 days plus CIS (10 mg/kg) single i.p. on fif5th day; group IV was given the same as group III plus nitro-ω-L-arginine (L-NNA) (25 mg/kg/d) orally for 7 days. Key findings CIS-induced cardiotoxicity and L-NNA co-administered group showed significant increases in cardiac enzymes, toxic histopathological features, elevated heart weights, angiotensin II (Ang II), neprilysin, malondialdehyde (MDA), inflammatory mediators, blood pressure (BP) and caspase 3 expressions, but there are significant decreases in the antioxidant parameters, vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS). However, the co-administration of Sac/Val could ameliorate these changes of CIS.

Conclusion

Sac/Val has an important cardioprotective effect against CIS cardiotoxicity with the involvement of eNOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiotoxicityVascular Endothelial Growth Factor AMaleRatsAnimalsCisplatinInterleukin-6Toll-Like Receptor 4Tumor Necrosis Factor-alphaRats, WistarValsartanNitric Oxide SynthaseAminobutyratesBiphenyl Compounds

Stichwörter der Autor:innen

Toll-like receptorcardiotoxicitycisplatininterleukin 6

Substanzen

Vascular Endothelial Growth Factor ACisplatinInterleukin-6Toll-Like Receptor 4Tumor Necrosis Factor-alphaValsartanNitric Oxide SynthasesacubitrilAminobutyratesBiphenyl Compounds

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia, Egypt.
  • Department of Histology and Cell Biology, Faculty of Medicine, Minia University, El-Minia, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Minia University, El-Minia, Egypt.
  • Department of Cardiology, Faculty of Medicine, Minia University, El-Minia, Egypt.

ORCID-Profile: Marwa Monier Mahmoud Refaie, Rehab Ahmed Rifaai

Zitieren

APA

Mahmoud Refaie, M. M., Ahmed Rifaai, R., Bayoumi, A. M. A., & Shehata, S. (2023). Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgad049

Vancouver

Mahmoud Refaie MM, Ahmed Rifaai R, Bayoumi AMA, Shehata S. Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways. Journal of Pharmacy and Pharmacology. 2023. doi:10.1093/jpp/rgad049

BibTeX
@article{MahmoudRefaie2023,
  author = {Mahmoud Refaie, Marwa Monier and Ahmed Rifaai, Rehab and Bayoumi, Asmaa M A and Shehata, Sayed},
  title = {Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2023},
  doi = {10.1093/jpp/rgad049}
}
Kostenlos starten →